Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.700
+0.130 (5.06%)
Aug 4, 2026, 3:19 PM EDT - Market open
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $60.65 million as of August 4, 2026. Its market cap has increased by 133.57% in one year.
Market Cap
60.65M
Enterprise Value
13.17M
1-Year Change
133.57%
Ranking
Category
Stock Price
$2.70
ChartMarket Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $60.65M, a decrease of -82.96%. That is a compound annual growth rate of -52.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 60.65M | 125.79% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 64.20M |
| ImageneBio | 62.49M |
| MindWalk Holdings | 60.26M |
| PMV Pharmaceuticals | 59.20M |
| Cardiff Oncology | 58.48M |
| Inovio Pharmaceuticals | 55.70M |
| Dogwood Therapeutics | 55.15M |
| Context Therapeutics | 55.07M |